Dr. Westby G. Fisher is a cardiologist at NorthShore University HealthSystem who writes regularly at Dr. Wes.
More from Dr. Wes
With the increasing push for medical records to go electronic, I continue to be amazed at the ability and speed that information gets pushed my way.
I have already mentioned the multiple servers that we must interact with daily, and today learned that soon our pacemaker checks will soon become “paperless,” permitting me the ability to log on to yet another server so I can sign my pacemaker checks electronically! Whooo Hooo!
Health Benefit Consultants, Share Your Expert Insights in Our Survey
Westby G. Fisher, MD Website Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist (doctor specializing in heart rhythm disorders) practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical Associate Professor of Medicine at University of Chicago's Pritzker School of Medicine. He entered the blog-o-sphere in […]
Not that this is bad, mind you. I think it’s great that all of this information will eventually be added on-line for all to see. There is no doubt that communication will be improved.
But despite the gleeful enthusiasm of the information technology gurus, I find that I am increasingly becoming the log jam that prevents the information from flowing to the electronic medical record. As more and more results and reports require the electronic signature, it is becoming increasingly difficult for some of us who do not spend the day at the computer screen to promptly sign our results and move them to the chart. The IT specialists and administrators realize that someone has to take the fall if there is a problem amongst all those results, so all of them pass before the doctor. But few of these technology people realize how long it takes to scroll down to find the results of a test that appears below a tiny pop-up window or the time it takes to decompress a pdf file on each test result reported. Multiply those times by hundreds of results or reports a day and it’s no wonder doctors remain skeptical of a computer’s ability to save us time. The more tests and electronic signature requirements must pass beneath my typing fingers, there is a limit as to how fast it can find its way to the patient’s chart.
Of course the IT specialists are all to happy to point out that you can highlight all of the results at once and click “Sign-‘Em-All” and, presto, they’re on the chart. But doesn’t that defeat the purpose of checking and reviewing the results? Sadly, I fear that human nature will do just that as doctors look for ways to relieve the log jam that appears in their result inbasket each day.
But then again, since the computer will get its “signature” with the click of a button, we’ll have 100 percent compliance with reviewing all our test results, won’t we?
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Westby G. Fisher, MD, FACC is a board certified internist, cardiologist, and cardiac electrophysiologist (doctor specializing in heart rhythm disorders) practicing at NorthShore University HealthSystem in Evanston, IL, USA and is a Clinical Associate Professor of Medicine at University of Chicago's Pritzker School of Medicine. He entered the blog-o-sphere in November, 2005. He writes regularly at Dr. Wes. DISCLAIMER: The opinions expressed in this blog are strictly the those of the author(s) and should not be construed as the opinion(s) or policy(ies) of NorthShore University HealthSystem, nor recommendations for your care or anyone else's. Please seek professional guidance instead.
